London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Apollon shares were flat at 0.11 pence each on Tuesday afternoon on the AQSE in London. They are down 70% from 0.37 pence each about a year ago on February 14, 2023.
https://www.lse.co.uk/news/apollon-formularies-hails-cancer-killing-results-published-in-journal-4scbjfczedcsnfj.html
Https://www.investegate.co.uk/announcement/prn/apollon-formularies-plc--apol/cancer-cell-killing-results-published-in-the-/8046654
Extract:
February 20, 2024
Apollon Formularies Plc
("Apollon" or the "Company")
APOLLON FORMULARIES SUCCESSFUL CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)
London, England - Apollon Formularies PLC (AQUS:APOL), an innovator in medical cancer research, proudly announces the peer-reviewed publication of their groundbreaking achievement in pre-clinical testing of Apollon's cancer therapeutic formulations.
Andrew REC m8.........................
Https://www.facebook.com/people/Apollon-Formularies/100054242870962/?ref=embed_page
"In September 2023, the Company signed a letter of intent with Supernature Co., Ltd for an Exclusive License Agreement for Thailand. Both Apollon and Supernature are currently working on the terms of the final Exclusive Licence Agreement which will be announced to the market in due course. "
Https://polaris.brighterir.com/public/apollon_formularies/news/rns/story/x2ev67x
The first half of 2023 was a busy and successful period for Apollon, and we are excited about the Company's prospects as we look towards 2024.
We are working extensively on ways in which to access the global market, by expanding our current capabilities to contract manufacturing in international GMP facilities in addition to the manufacturing, production operations and export opportunities we have currently in Jamaica. The Company is working closely with our international partners to produce and distribute Apollon’s proprietary formulations. We will keep the market updated with any new developments.
We would like to thank our shareholders for their continued support and investment as we continue to work towards our goal of becoming the premier global medical cannabis and medicinal mushroom company in oncology and chronic pain.
Thanks, i used the number off here which is wrong
Trade showing now, amount reads £231.30 and up 8.33% fast legs......................... LOL
Todays trade not showing here, maybe a 15 min delay, I don't know for sure..................
Latest Trades
Date Volume Price (GBX) Value (GBP)
22 Sep 23
11:17
115,940 0.20 231.88
21 Sep 23
12:28
262,358 0.17 446.01
21 Sep 23
09:32
292,624 0.15 438.94
20 Sep 23
14:09
100,000 0.10 100.00
20 Sep 23
14:07
500,000 0.13 650.00
Moved up again now at 0.20 ask
https://www.aquis.eu/companies/APOL
Number 4 on aquis stock exchange Share risers today............ Free PR
And spread drop.....................
She has fast legs on only small buys...........................
I posted that the other day, thinking the question may come up..............
Unvrkw - I think you will find that there are now 748,376,677 shares now in circulation.
There’s 31 million shares and it’s being bought for equivalent of £4.2 million. that’s 13 p a share
APOL number one, top riser............
Share Price Change
Apollon Formular... (APOL.PL) 0.15 +20.00%
https://www.lse.co.uk/aqse-share-prices/
Plus 12%
:+)
Buy price moving up....now 0.17 to buy.
You're welcome Andrew......................
Was hoping for more blue days..................
Hi Kenny, thanks for the link.
Let's hope the whole is worth a lot more than the sum of the parts and the combined businesses are able to exploit the global demand for cannabis based medical and other products.
The Interim Report is due before the end of this month, so hopefully there may be further information there.